Engagement of phytoestrogens in breast cancer suppression: Structural classification and mechanistic approach
Authors:
- 1 March 2021
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 213, 113037
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research, India
This publication has 218 references indexed in Scilit:
- Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2BMC Pharmacology and Toxicology, 2013
- Plant Sterols as Anticancer Nutrients: Evidence for Their Role in Breast CancerNutrients, 2013
- Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC–MS/MS and their pharmacokinetics in dogsJournal of Pharmaceutical and Biomedical Analysis, 2012
- Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in ratsCancer Chemotherapy and Pharmacology, 2010
- Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) StudyBreast Cancer Research and Treatment, 2009
- Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cellsCytotechnology, 2009
- Liquiritigenin is a plant-derived highly selective estrogen receptor β agonistMolecular and Cellular Endocrinology, 2008
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004
- Flavonoids: antioxidants or signalling molecules?Free Radical Biology and Medicine, 2004
- Structure-antioxidant activity relationships of flavonoids and phenolic acidsFree Radical Biology and Medicine, 1996